Geri
Orthocell Ltd (ORHHF) Fiyatı
ORHHF Hisse Senedi Fiyat Grafiği
ORHHF Kazanmak
Orthocell Ltd
$0
0%
$0
Kapanışta: Jan 16, 16:00:00 GMT-5
$0
0%
$0
Sonrası Piyasa: Jan 16, 20:00:00 GMT-5
Earnings FAQ
ORHHF'ün son EPS'si beklentilerle karşılaştırıldığında nasıldı?
Orthocell Ltd ORHHF'ün son çeyrekteki geliri nasıl performans gösterdi?
Orthocell Ltd'in gelir tahmini nedir?
Orthocell Ltd'in kazanç kalite puanı nedir?
Orthocell Ltd kazançlarını ne zaman rapor eder?
Orthocell Ltd'in beklenen kazançları nelerdir?
Orthocell Ltd kazanç beklentilerini aştı mı?
Önemli İstatistikler
Önceki Kapanış
--
Açılış fiyatı
--
Günün Aralığı
-
52 haftalık aralık
-
İşlem hacmi
--
Ort.Hacim
--
EPS (TTM)
--
Dividend yield
--
Piyasa Değeri
--
ORHHF nedir?
Orthocell Ltd. engages in the business of developing and commercializing biological medical devices and cell therapies. The company is headquartered in Perth, Western Australia. The company went IPO on 2014-08-12. The firm is focused on regenerating mobility for patients by developing products for the repair of a variety of bone and soft tissue injuries. Its portfolio of products includes Striate+, Remplir, and OrthoACI. Striate+ is an acellular resorbable collagen membrane used for guided bone and tissue regeneration in dental applications. Remplir is a collagen-based nerve wrap designed to support nerve repair surgery in peripheral nerve repair. OrthoACI, or Autologous Chondrocyte Implantation, offers treatment for symptomatic defects of the articulating cartilage of the joints. OrthoACI uses the patient’s own healthy cartilage cells called chondrocytes to assist the regeneration of damaged cartilage. The firm is engaged in the development of its tendon cell therapy in the United States. Its autologous tendon therapy is an advanced injectable cellular therapy for the treatment of chronic tendon injuries.
Özellikler
Ticaret Stratejileri
Kaynaklar
© 2025 Finture Development Limited. All rights reserved